Discovery of Novel Sesquiterpene Lactone Derivatives as Potent PKM2 Activators for the Treatment of Ulcerative Colitis
作者:Ping Wang、Hongqiong Yang、Weijiang Lin、Jingxian Zhou、Yi Liu、Lingyu Ma、Mengting Li、Yang Hu、Chengli Yu、Yinan Zhang、Qi Lv、Jian Liu、Lihong Hu
DOI:10.1021/acs.jmedchem.2c01856
日期:2023.4.27
The pyruvate kinase M2 (PKM2) can significantly affect the differentiation of Th17 and Treg cells; thus, it is considered a promising target for UC therapy. Herein, five series of costunolide (Cos) derivatives are designed, synthesized, and biologically evaluated. Among them, D5 exhibits excellent immunomodulatory activity against T-cell proliferation and potent PKM2 activating activity. Meanwhile, it
丙酮酸激酶M2(PKM2)可显着影响Th17和Treg细胞的分化;因此,它被认为是 UC 治疗的一个有前途的靶点。在此,设计、合成了五个系列的木香烯内酯(Cos )衍生物,并进行了生物学评价。其中,D5对 T 细胞增殖表现出优异的免疫调节活性和有效的 PKM2 激活活性。同时,已证实D5也能与PKM2的Cys424共价相互作用。分子对接和分子动力学 (MD) 研究表明,D5的二氟环丙基衍生物通过与 Arg399 静电相互作用改善蛋白质-配体相互作用。此外,D5显着抑制 Th17 而非 Treg 细胞的分化,从而恢复 Th17/Treg 平衡,这归因于抑制 PKM2 介导的糖酵解。口服D5可改善小鼠模型中葡聚糖硫酸钠 (DSS) 和 2,4,6-三硝基苯磺酸 (TNBS) 诱导的结肠炎症状。总的来说,D5有潜力被开发为新型抗 UC 候选药物。